Ashley Ghiaseddin, MD
University of Florida
6
6
0
N/A
0
6
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+5 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (6)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Duane Mitchell, MD, PhD
University of Florida
Shared therapeutic areas:
Worked with same sponsors:
Jeffrey Raizer, MD
Northwestern University
Shared therapeutic areas:
Worked with same sponsors:
Jaymes Holland
Alaunos Therapeutics
Shared therapeutic areas:
Daniel Landi, MD
Duke University
Shared therapeutic areas:
Worked with same sponsors:
Kevin A camphausen, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Worked with same sponsors:
Annick Desjardins, MD, FRCPC
Duke University
Shared therapeutic areas:
Maryam Fouladi, MD
Nationwide Children's Hospital
Shared therapeutic areas:
Michael B Gill
Power Life Sciences Inc.
Shared therapeutic areas:
David A. Reardon, MD
Duke Health
Shared therapeutic areas:
Alina Markova, MD
Memorial Sloan Kettering Cancer Center
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (6)
Showing 6 of 6 trials
OPTIMUS PRIME: Safety and Feasibility of OPTune GIO® Integrated With MRI-gUided Laser Ablation Surgery and Pembrolizumab for Recurrent GlIoblastoMa, A randomizEd Trial
RNA-Lipid Particle (RNA-LP) Vaccines for Recurrent Adult Glioblastoma (GBM)
ADAGiO: Adoptive Cellular Therapy for the TreAtment of Recurrent OliGodendrogliOma (OG) Adult Patients
IL-8 Receptor-modified CD70 CAR T Cell Therapy in CD70+ Adult Glioblastoma
RENEW: Feasibility of CMV RNA-Pulsed Dendritic Cells Vaccines for the Treatment of Newly Diagnosed Glioblastoma Patients.
Study Testing The Safety and Efficacy of Adjuvant Temozolomide Plus TTFields (Optune®) Plus Pembrolizumab in Patients With Newly Diagnosed Glioblastoma (2-THE-TOP)
All 6 trials loaded